Atossa Therapeutics Joins ARDD 2026 Clinical Trials Panel
Seattle, Washington, U.S., September 24, 2026 Atossa Therapeutics Inc. announced that its Chief Executive Officer and Founder, Dr. Steven...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Seattle, Washington, U.S., September 24, 2026 Atossa Therapeutics Inc. announced that its Chief Executive Officer and Founder, Dr. Steven...
Minneapolis, Minnesota, U.S., September 24, 2026 Marani Health has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
London, United Kingdom, September 22, 2026 Smith+Nephew has announced U.S. FDA 510(k) clearance for its LANDMARKâ„¢ Total Knee System...
Tel Aviv, Israel, September 9, 2026 AEYE announced publication of clinical-trial findings evaluating AEYE-DS, an autonomous artificial intelligence-based screening...
San Jose, California, September 9, 2026 Emboline has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its...
Brussels, Belgium, September 9, 2026 UCB announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
Baltimore, Maryland, September 9, 2026 CraniUS Therapeutics has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the...
Herzliya, Israel, September 1, 2026 Medibyt, a digital health company focused on cardiopulmonary diagnostics, has announced that the U.S....
Salt Lake City, Utah, August 6, 2026 BlueWind Medical, Ltd. has received U.S. Food and Drug Administration (FDA) 510(k)...
VANCOUVER, BC, July 30, 2026 Total Flow Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
